Keyword: janet-marchibroda
Cybersecurity and Medical Devices: Risk Assessment and Response
Join us to examine cybersecurity risks associated with medical device technology and the strategies and policies that can help address such risks.
Senate HELP Committee’s Passage of Bipartisan FDA Reauthorization Important Milestone for Patients
The Bipartisan Policy Center applauds the Senate HELP Committee for passing the Food and Drug Administration Reauthorization Act of 2017.
Patient Safety and Information Technology
IT plays a key role in preventing many medical errors by offering clinical decision support and better communication between clinicians and patients.
We can improve and modernize the drug development process
The bigger concern is the fact that it takes more than ten years and $2 billion to develop a new drug from a molecule to a medicine.
What Opportunities Will Congress And President Have To Improve Health Policy?
While ideological divides on health care policy remain wide, the next Congress and administration will face several key issues that will require bipartisan collaboration to address.
BPC Comments on Proposed Prescription Drug User Fee Act
BPC applauds FDA’s efforts to incorporate enhancements to accelerate the development and delivery of safe and effective treatments and cures to patients.
BPC Comments on Health IT Legislation
While a majority of clinicians and hospitals are now adopting electronic health records, the level of information sharing among different organizations is still fairly low.
BPC Comments to Senate Finance Committee on Chronic Care Policy Options
BPC has released a number of reports that included recommendations to better organize and integrate our health care system to lower costs and improve quality of care.
On Cancer ‘Moonshot,’ Time is Ticking for Biden
Biden will lead a task force composed of five government departments and nearly 10 offices, institutes and agencies from across the sprawling federal apparatus.
BPC aims to develop recommendations for speeding medical innovation
BPC kicked off its FDA: Advancing Medical Innovation initiative, with the first session addressing how to accelerate the discovery, development and delivery of medical products.
Dialogue: Issue V
